Clinical Trials Directory

Trials / Completed

CompletedNCT04720898

LUNA-EMG to Enhance Motor Functions in Multiple Sclerosis

LUNA-EMG to Enhance Lower Limb Motor Functions in Multiple Sclerosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
University of Liege · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The aim of the present study is to evaluate the effects of training performed with the LUNA-EMG system to enhance motor functions of the lower limb in multiple sclerosis. This is a randomized open-label trial. Patients will be randomized into the intervention group (LUNA-EMG, 30-45 minutes once a week for 12 weeks) or in the control group (standard care). The effect of the training will be measured based on the muscular strength, walking tests, proprioception and a quality of life questionnaire.

Conditions

Interventions

TypeNameDescription
DEVICELUNA-EMGThe LUNA-EMG (Samcom) system is a robot that allows the evaluation of muscular strength through the recording of muscle activity (electromyography - EMG) in order to provide precise objective data on the patient's muscle function. In addition to the diagnostic aspect (evaluation of muscle strength, range of motion and proprioception), the LUNA-EMG robot provides optimized range of motion's movements and a visual feedback on the patient's performance. In addition, it may enhance neuroplasticity due to the increased number of movements repetitions which could influence motor learning.

Timeline

Start date
2021-03-01
Primary completion
2024-06-01
Completion
2024-06-01
First posted
2021-01-22
Last updated
2025-08-05

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04720898. Inclusion in this directory is not an endorsement.